Effects of Age, Gender and Obesity on the Single Dose Pharmacokinetics (PK) of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor

被引：0
|
作者：
Addy, Carol
Tatosian, Daniel
Hou, Xiaoli S.
Gendrano, Isaias N.
Martucci, Ashley
Wagner, John A.
Stoch, S. Aubrey
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1157-P
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [1] Single-/Multiple- Dose Pharmacokinetics (PK) and Pharmacodynamics (PD) of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, in Healthy Subjects
    Krishna, Rajesh
    Addy, Carol
    Tatosian, Daniel
    Hou, Xiaoli S.
    Gendrano, Isaias N.
    Martucci, Ashley N.
    Wagner, John A.
    Stoch, S. Aubrey
    [J]. DIABETES, 2013, 62 : A284 - A284
  • [2] Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects
    Krishna, Rajesh
    Addy, Carol
    Tatosian, Daniel
    Glasgow, Xiaoli S.
    Gendrano, Isaias Noel, III
    Robberechts, Martine
    Haazen, Wouter
    de Hoon, J. N.
    Depre, Marleen
    Martucci, Ashley
    Peng, Joanna Z.
    Johnson-Levonas, Amy O.
    Wagner, John A.
    Stoch, S. Aubrey
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1528 - 1537
  • [3] Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men
    Tsuchiya, Saori
    Friedman, Evan
    Addy, Carol
    Wakana, Akira
    Tatosian, Daniel
    Matsumoto, Yuki
    Suzuki, Hideyo
    Kauh, Eunkyung
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (01) : 84 - 92
  • [4] PHARMACOKINETICS OF OMARIGLIPTIN (MK-3102), A ONCE-WEEKLY DIPEPTIDYL PEPTIDASE-IV (DPP-4) INHIBITOR, IN PATIENTS WITH RENAL IMPAIRMENT
    Tatosian, D. A.
    Glasgow, S.
    Caceres, M.
    Grenier, J.
    DeGroot, B.
    Ward, T.
    Johnson-Levonas, A.
    George, L.
    Lasseter, K. C.
    Marbury, T. C.
    Kauh, E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S90 - S90
  • [5] Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes
    Kawasaki, Eiji
    Nakano, Yuko
    Fukuyama, Takahiro
    Uchida, Aira
    Sagara, Yoko
    Tamai, Hidekazu
    Tojikubo, Masayuki
    Hiromatsu, Yuji
    Koga, Nobuhiko
    [J]. WORLD JOURNAL OF DIABETES, 2021, 12 (12) : 2087 - 2095
  • [6] Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of Multiple-Dose Administration of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, in Obese Subjects With and Without Type 2 Diabetes Mellitus (T2DM)
    Addy, Carol
    Tatosian, Daniel
    Hou, Xiaoli S.
    Gendrano, Isaias N.
    Martucci, Ashley
    Groff, Michelle
    Wagner, John A.
    Stoch, S. Aubrey
    [J]. DIABETES, 2013, 62 : A287 - A287
  • [7] Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Goldenberg, Ronald
    Gantz, Ira
    Andryuk, Paula J.
    O'Neill, Edward A.
    Kaufman, Keith D.
    Lai, Eseng
    Wang, Yin Na
    Suryawanshi, Shailaja
    Engel, Samuel S.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (03): : 394 - 400
  • [8] Cardioprotective effects of dipeptidyl peptidase-4 (DPP-4) inhibitors independently of DPP-4
    Yamaguchi, T.
    Yasukatsu, I.
    Yamazaki, T.
    Nakamura, Y.
    Shimada, K.
    Yoshiyama, M.
    Iwao, H.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 777 - 777
  • [9] Absorption, Metabolism, and Excretion of [14C] Omarigliptin, a Once-Weekly DPP-4 Inhibitor, in Humans
    Xu, Shiyao
    Kauh, Anya
    Tatosian, Daniel
    Mcintosh, Ian
    Caceres, Maria
    Matthews, Catherine
    Miller, Jutta
    Kumar, Sanjeev
    Wirth, Mark
    [J]. DIABETES, 2014, 63 : A281 - A281
  • [10] Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans
    Xu, Shiyao
    Tatosian, Dan
    Mcintosh, Ian
    Caceres, Maria
    Matthews, Catherine
    Samuel, Koppara
    Selverian, Diana
    Kumar, Sanjeev
    Kauh, Eunkyung
    [J]. XENOBIOTICA, 2018, 48 (06) : 584 - 591
12345